Intellectual Property Firm
“Companies across the world have come to depend on Matthias Scholl for developing & protecting their intellectual property assets.”
Overview
Matthias Scholl is a law firm focused exclusively on intellectual property law, with particular emphasis on patent and trademark prosecution.
We advance our clients’ interests through careful legal analysis, innovative problem-solving, and dedicated representation. Our work is guided by a strong commitment to quality, practical judgment, and responsiveness. This approach reflects our genuine focus on our clients’ objectives and has resulted in long-standing client relationships and referrals worldwide.
Founder
Dr. Matthias Scholl is the founder and administrative head of the firm.
Dr. Scholl’s academic background includes:
- Doctor of Laws (J.D.), Harvard Law School
- Doctor of Philosophy (Ph.D.) in Organic Chemistry, California Institute of Technology, for work contributing to research recognized by the 2005 Nobel Prize in Chemistry awarded to Prof. Robert H. Grubbs
- Doctor of Medicine (M.D.), International University of the Health Sciences
- Three Bachelor of Science (S.B.) degrees from the Massachusetts Institute of Technology, with a triple major in chemistry, chemical engineering, and foreign languages and literatures
Dr. Scholl is a registered patent attorney admitted to practice before the United States Patent and Trademark Office. He is also admitted to the Massachusetts Bar and to the United States Court of Appeals for the Federal Circuit.
Patent Metrics
1612
Granted U.S. Patents
582
Clients Worldwide
131
Patents for Largest Client
2.54
Average Patents per Client
2001-03-15
Earliest Filing Date
2006-03-21
Earliest Issue Date
2026-05-26
Most Recent Issue Date
4.37
Fastest Pendency (months)
27.11
Average Pendency (months)
Top Patent Classes
- H02K - DYNAMO-ELECTRIC MACHINES
- A24F - SMOKERS’ REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- H02P - CONTROL OR REGULATION OF ELECTRIC MOTORS, ELECTRIC GENERATORS OR DYNAMO-ELECTRIC CONVERTERS; CONTROLLING TRANSFORMERS, REACTORS OR CHOKE COILS
- G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- C02F - TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- F04D - NON-POSITIVE-DISPLACEMENT PUMPS
- B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01D - SEPARATION
Latest News
Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
By Kevin E. Noonan – In a decision that, in retrospect, is not surprising (in view of the haste with which the Court took up the case after granting certiorari; see “Solicitor General Proves Persu...
Read Full ArticleThe World Cup Comes to Miami: Behind the Scenes
When fans think about the FIFA World Cup, they picture the matches, the players, the national pride, the fan festivals, and the extraordinary global energy surrounding the tournament. What they rarely...
Read Full ArticleYou Had Your Chance: Director Squires Slams the Door on Second-Bite IPR Petitions
Background - In a precedential Director discretionary denial issued May 14, 2026, USPTO Director John A. Squires denied institution of inter partes review in Magnolia Medical Technologies, Inc. v. Kur...
Read Full ArticlePotential Implications of Ollnova on Patent Prosecution Strategies
Our Intellectual Property Group examines a Federal Circuit decision that strengthens the case for software and network-based patents whose claims are grounded in specific technical solutions rather th...
Read Full ArticleNCAA Athletes Fight To Limit Review Of Third-Party NIL Deals
College athletes urged a California federal magistrate judge Wednesday to find their deals with multimedia rights companies and third-party brand sponsors aren't subject to oversight by the College Sp...
Read Full ArticleAI Training and Fair Use
While the legal landscape is continuing to take shape, a number of recent court decisions indicate that unlicensed use of copyrighted data to train AI models generally constitutes fair use. Each fair ...
Read Full ArticleDoes the USPTO Issue “Secret Patents” on Aerospace Innovations?
Despite periodic mentions by aerospace innovators of “secret patents,” this author is not aware of any evidence of such patents. There may be confusion with “Secrecy Orders,” which apply to pa...
Read Full ArticleActelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
The measurement of the hydrogen ion concentration in an aqueous solution is represented (on a logarithmic scale) as the pH, wherein water under ambient conditions (a temperature of 25°C) has a neutra...
Read Full ArticleDon’t Tank Your Valuation: IP Mistakes AI Founders Make Before Exit
You built something real. Now you want to get paid: whether through acquisition, fundraise, or IPO. But a few preventable mistakes can crater your valuation or kill a deal entirely. Here’s what to l...
Read Full ArticleWashington Becomes the Latest State to Expand Right of Publicity Protections to Digital Replicas
This article is part of DWT's The Generative Slate Series. It explores the use of generative AI in the production and distribution of content....By: Davis Wright Tremaine LLP...
Read Full ArticleBeyond Skinny Labels: Supreme Court Clarifies Limits of Induced Infringement Claims
On June 4, in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., the Supreme Court unanimously reversed the Federal Circuit, holding that a complaint for induced infringement must “plausibly all...
Read Full ArticleWhite House Guidance on AI Framework May Conflict with Executive Order from CA
On March 20, 2026, the White House released a National AI Legislative Framework calling for Congress to create a comprehensive national standard for AI regulation. The Framework called out a variety o...
Read Full ArticlePTAB Invalidates Inari Embolism Treatment Patent
The Patent Trial and Appeal Board has invalidated the entirety of an Inari Medical Inc. patent covering the company's thrombectomy products, in a challenge brought by Imperative Care Inc....
Read Full ArticleTrading Claims for Speed: USPTO Sweetens the Streamlined Claim Set Pilot
USPTO waives the petition fee for its Streamlined Claim Set Pilot Program, offering free expedited first Office actions for lean claim sets. Continue reading this post on Patently-O....
Read Full ArticlePresident Trump Nominates Five Commissioners to Restore the U.S. International Trade Commission to Full Strength
President Donald Trump has now nominated a full slate of five candidates to (1) fill the three vacant seats on the US International Trade Commission (“ITC” or “Commission”), and (2) replace tw...
Read Full ArticleInfluencer Says Underwear Co. Posted Lewd Deepfake
A lifestyle content creator has sued body-inclusivity-oriented underwear company EBY Inc., claiming that while she had agreed to be a brand ambassador, the company used artificial intelligence to crea...
Read Full ArticleGreenberg Traurig Hires 2 IP Litigators From Goodwin Procter
Greenberg Traurig LLP announced Wednesday that it had brought on two veteran litigators from Goodwin Procter LLP to its New York office, bolstering its intellectual property litigation practice as the...
Read Full ArticleBroker Says Ex-Employee Moved 800 Clients To Rival
An insurance brokerage urged a Colorado federal judge Wednesday to block three former employees and a rival from using allegedly stolen trade secrets, saying a senior broker took confidential customer...
Read Full ArticleOne Question Too Few: A Win on Eligibility Undone by the Verdict Form
In Ollnova Technologies Ltd. v. ecobee Technologies ULC, the Federal Circuit handed Ollnova a string of doctrinal wins — three of its four patents cleared the patent eligibility hurdle under 35 U.S....
Read Full ArticleOne And Done? Patent Examiner Interviews Now Hard To Get
In the months since the U.S. Patent and Trademark Office changed how patent examiners are credited for applicant interviews, which can be the difference between prosecution stalemates and progress, at...
Read Full ArticleColo. Co. Says Boeing Tolled Contract Claim In NASA IP Suit
A Colorado aerospace company has told a Washington federal judge that its breach of contract claim against The Boeing Co. alleging theft of its patented technology was timely and that Boeing's bid to...
Read Full ArticleIPWatchdog Patent Masters Urge Stakeholders to Unite for Change in the Next Cycle of U.S. Patent Reform
IPWatchdog’s 2026 Patent Masters Program kicked off Monday with discussions on the state of the international patent landscape and the role of artificial intelligence (AI) in creating efficiency gai...
Read Full ArticleJudge Cuts IP Suit, Sees Error In Defendant's AI-Assisted Brief
A Colorado federal judge has narrowed two claims in an Alaska tribal corporation's suit against a consultant and her business and told an attorney for the consultant to explain why she shouldn't be sa...
Read Full ArticleGoSecure's Patent Case Should Stay Alive, Judge Says
A Texas federal judge has suggested that Austin-based CrowdStrike Inc. shouldn't be allowed to escape a suit accusing it of infringing a computer system monitoring patent, saying the allegations are s...
Read Full ArticleFanDuel Must Face Patent Infringement Suit Over Apps
A New Jersey federal judge has trimmed a lawsuit alleging FanDuel unlawfully uses WinView IP Holdings' patented technology for online and mobile gambling, allowing claims for direct infringement of tw...
Read Full ArticleEU, African Countries Reach First-Of-Its-Kind Trade Deal
The European Union and four African countries have reached a deal on the bloc's first free trade agreement with sub-Saharan African nations in the hopes of mutual economic benefits, the European Commi...
Read Full ArticleProtecting AI-Driven Innovation In Life Sciences IP
Recent developments, including the U.S. Patent and Trademark Office's evolving inventorship standards, and the impact of artificial intelligence on the "person of ordinary skill in the art" standard d...
Read Full ArticleIP Notebook: Cox's Reach, 'Top Gun' Appeal, 'Lazy' Videos
This round of Law360's review of emerging copyright and trademark issues looks at the ripple effects from the U.S. Supreme Court's ruling on secondary copyright liability and highlights looming high c...
Read Full ArticlePTAB Upholds 1 Stratasys Patent, Axes Claims In Another
The Patent Trial and Appeal Board has invalidated certain claims in a 3D printing patent owned by U.S.-Israeli company Stratasys, but agreed to keep the claims in another patent alive in challenges la...
Read Full Article$25M Patent Verdict Against Ferring Backed By Del. Court
Swiss drugmaker Ferring Pharmaceuticals Inc. on Wednesday lost its bid to dodge a $25 million verdict in a Delaware federal court patent case over an experimental enema used to treat a particularly de...
Read Full ArticleSupreme Court Clarifies Pleading Standard for Induced Infringement in Hikma v. Amarin
On June 4, the Supreme Court unanimously decided Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. This case concerns the requirements for induced infringement, specifically in the context of “...
Read Full ArticleSupreme Court clarifies limits of induced infringement liability for skinny labels
The U.S. Supreme Court has now issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., unanimously reversing the Federal Circuit and narrowing the circumstances in which generic ...
Read Full ArticleFirst Jury Verdict For Private Plaintiffs In Pay-For-Delay Litigation Results In $885 Million Award
On May 18, 2026, a jury in the U.S. District Court for the District of Massachusetts, in a case before Judge Myong J. Joun, returned a verdict finding a global pharmaceutical company liable for approx...
Read Full ArticlePatent Fee-Shifting after mCom, Realtime and Dragon - What Changed in the Enforcement Calculus
Patent enforcement has always required two decisions, not one. The first is the obvious question: can the patent owner prove infringement and survive the expected validity challenges? The second...
Read Full ArticleThe EU design reform is crossing the finish line
The new EU design legislation aims to modernize the EU design system and to provide design protection that is fit for the era of digital designs and evolving technologies. The second stage of the EU d...
Read Full ArticleThe Register of Copyrights Is Wrong About Cox v. Sony
At a recent Senate Judiciary Subcommittee hearing, Register of Copyrights Shira Perlmutter noted that Congress may need to overturn this year’s unanimous decision in the Cox v. Sony Supreme Court ca...
Read Full ArticleArbitrator Rules USPTO Violated Federal Labor Law by Eliminating Non-Patents Employee Telework Without Bargaining
On Monday, an arbitrator issued an order finding that the U.S. Patent and Trademark Office (USPTO) violated federal labor law when it eliminated routine and remote telework for non-Patents bargaining ...
Read Full ArticleAI, Patent Strategy, and What Actually Drives Outcomes in 2026 – Part 3
Investment Committee Takeaways - Agentic AI is changing diligence from a fixed workstream into a continuously operating risk engine. The core question is no longer whether a portfolio looks strong; it...
Read Full ArticleAI-Enhanced Misappropriation: When Departing Employees Leave with More Than Just Client Lists
Consider the scenario: a higher-up employee uploads six months of internal strategy documents into a generative AI tool, generates a ten-page competitive playbook synthesizing the company’s pricing ...
Read Full ArticleArbitrator Rules USPTO Violated Law By Ending Telework
An arbitrator ruled Monday that the U.S. Patent and Trademark Office "committed a clear and patent breach" of agreements with the union representing some of its employees when the office eliminated te...
Read Full ArticleAnthropic, Other Tech Giants Get Authors' Copyright Suit Split
A group of writers, including Pulitzer Prize-winning journalist John Carreyrou, will have to pursue their claims of copyright infringement against Anthropic, Apple, Google, Perplexity AI, Nvidia and x...
Read Full ArticleMorrison Foerster Brings On Sidley Patent Litigation Duo
A pair of Sidley Austin LLP patent and trade secrets litigators, including the firm's co-leader of its global intellectual property practice, have departed for Morrison Foerster LLP, according to an a...
Read Full ArticleAtty Looks For Early Win In Defamation Row With Pot Co.
A Montana intellectual property attorney and his wife are looking to end a cannabis cultivator's defamation lawsuit accusing them of posting falsehoods on social media about the business and making fa...
Read Full Article9th Circ. Grants Rare Rehearing In Kat Von D Tattoo Fight
The Ninth Circuit agreed Tuesday to take the rare step of having a larger panel rehear a copyright dispute over Kat Von D's Miles Davis tattoo, vacating a ruling that upheld the celebrity tattoo artis...
Read Full ArticleFederal Circuit Reverses PTAB Findings of Unpatentability for Google’s ‘Hotword’ Patents
The U.S. Court of Appeals for the Federal Circuit (CAFC) on Tuesday reversed and remanded two Patent Trial and Appeal Board decisions that had found Google’s patents for improvements to “hotword...
Read Full Article6 Questions to Ask Before Filing an IPR Petition
On October 17, 2025, USPTO Director John Squires issued a memorandum announcing that he would be sole decision-maker for institution of inter partes review (IPR) and post-grant review (PGR) proceeding...
Read Full ArticleHikma v. Amarin and a Clarified Standard for Induced Patent Infringement Under 35 U.S.C. § 271(b)
In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (June 4, 2026), a unanimous Supreme Court has further clarified what it takes to plead — and ultimately prove — that a defendant induced an...
Read Full ArticleReadily Ascertainable - WilmerHale's Trade Secret Bulletin: March and April 2026
Welcome to WilmerHale’s bulletin on recent trade secret case law and relevant news items. We’ve affectionately nicknamed it “Readily Ascertainable” because, unlike a trade secret, it should be...
Read Full ArticleSupreme Court Clarifies ‘Skinny Label’ Induced Infringement Standard, Backing Generic Drugmakers
The Supreme Court unanimously ruled in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., No. 24-889, that a branded pharmaceutical company alleging induced patent infringement against a generic ma...
Read Full ArticleThe AI Arms Race Runs Through the Patent System | IPWatchdog Unleashed
This week on IPWatchdog Unleashed, I spoke with Rama Elluru, a former PTAB Judge turned national security policy advisor. We explore the accelerating intersection of AI, patent law, and national compe...
Read Full ArticleSupreme Court Clarifies Requirements for “Active Steps” in Induced Patent Infringement Claims
Key Takeaways: Induced infringement requires clear affirmative conduct. Actions required by law, standard industry practices and omissions do not count as “active steps.”...By: Dinsmore & Shohl ...
Read Full ArticleInterpreting pH in Pharmaceutical Patent Claims: Lessons from Actelion v. Mylan
Key Takeaways - Leaving pH measurement conditions undefined let the court apply a default standard temperature, which defeated literal infringement......By: Dinsmore & Shohl LLP...
Read Full ArticleFederal Circuit Vacates Smart Thermostat Verdict, Clarifies Jury Instruction and Verdict Form Requirements
The Federal Circuit’s new precedential decision in Ollnova Technologies Ltd. v. ecobee Technologies ULC may have significant implications for how patent cases are tried, particularly in multi-patent...
Read Full ArticleFederal Circuit Affirms Indefiniteness Of "About" In Patent Claiming pH Range For Poultry Processing Method
On May 4, 2026, the United States Court of Appeals for the Federal Circuit (Judges Lourie, Prost, and District Judge Burroughs) affirmed a decision of the United States District Court for the Eastern ...
Read Full ArticleUSPTO Director Sends PTAB Unpatentability Decision To Rehearing Panel In Light Of Contrary Jury Verdict
In response to a request for a Director Review of a PTAB decision finding claims 1-4 and 6 of U.S. Patent No. 7,594,168 unpatentable, the Director of the United States Patent and Trademark Office (“...
Read Full ArticleU.S. Supreme Court Holds Generic Manufacturer's "Skinny Label" and Marketing Did Not Induce Patent Infringement
On June 4, 2026, Justice Ketanji Brown Jackson, writing for a unanimous Supreme Court of the United States, reversed a decision by the United States Court of Appeals for the Federal Circuit and held t...
Read Full ArticleFederal Circuit Affirms No Infringement in Pharmaceutical Patent Dispute Over pH Measurement Conditions For Epoprostenol Composition
On May 13, 2026, the U.S. Court of Appeals for the Federal Circuit (Judges Reyna, Taranto, and Stoll) affirmed a decision of the U.S. District Court for the Northern District of West Virginia finding ...
Read Full ArticleLatest Federal Court Cases: Hikma Pharms USA Inc. v. Amarin Pharma, Inc.
Hikma Pharms USA Inc. v. Amarin Pharma, Inc., Appeal No. 24-889 (Sup. Ct. June 4, 2026) - In its first patent case of 2026, the Supreme Court addressed a question of induced infringement as applied ...
Read Full ArticleDyson v. Dreame reloaded—Unified Patent Court grants Dyson another preliminary injunction in patent dispute over hair stylers
Dyson v. Dreame International, UPC_CFI_2255/2025, Hamburg Local Division, April 7, 2026 In April, the UPC granted Dyson Technology Limited (“Dyson”) a new preliminary injunction against several...
Read Full ArticleLaunching the High-Growth Startup: Key Legal and Financing Considerations
Building a successful high-growth startup requires more than just a strong business idea. As venture markets evolve and fundraising timelines shorten, companies with solid legal, governance, and finan...
Read Full ArticleNo “Skinny Dipping” into Liability: SCOTUS Delivers Win for Generic Drugs
The manufacture and distribution of generic pharmaceutical drugs is a polarizing topic in the political and legal world. The manufacturing and marketing of generic versions of brand-name drugs are all...
Read Full ArticleFederal Circuit Affirms PTAB Obviousness Rejection of Automated Kitchen System Patent Application
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision today in In re Zhengxu He, affirming a Patent Trial and Appeal Board (PTAB) decision upholding an examiner’s rejection of c...
Read Full ArticleFederal Circuit Clarifies Standing Requirements for Patent Owners
In a pair of May 2026 decisions, the Federal Circuit offered important guidance on what rights a patent owner must retain in a licensed patent and still have standing to sue. In a precedential opinion...
Read Full ArticleEnforceable, but Not Reviewable: A Breached Sotera Stipulation and § 314(d)
Hafeman v. Google: the Federal Circuit holds a breached Sotera stipulation is unreviewable under Section 314(d), leaving a one-sided trap. Continue reading this post on Patently-O....
Read Full ArticleExecutive Order on "Promoting Advanced Artificial Intelligence Innovation and Security"
On June 2, 2026, President Trump signed an Executive Order titled "Promoting Advanced Artificial Intelligence Innovation and Security" (the "Order"). The Order represents the Administration's latest a...
Read Full ArticleUPC Court of Appeal Clarifies Jurisdiction Over Non-UPC Patents in Fujifilm v Kodak
The UPC Court of Appeal has delivered an important ruling in Fujifilm v Kodak, confirming that the Unified Patent Court’s jurisdiction may extend to non-UPC European patent designations. The decisio...
Read Full ArticleA Practical Guide to IP Risk and Litigation in Data Center Development
As data centers integrate numerous advanced technologies within a single operating environment, they are becoming a natural focal point for intellectual property (IP) scrutiny, including patent disput...
Read Full ArticleThe Skinny Line Between Possible and Plausible
By now most people have heard that Hikma v. Amarin, No. 24–889 (June 4, 2026), was an overall favorable decision for skinny labeling. But what are the practical takeaways? Here we outline the fact...
Read Full ArticleCAFC Reverses EDTX Infringement and Damages Rulings, Upholds Denial of JMOL on Section 101
Last week, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Ollnova Technologies Ltd. v. ecobee Technologies ULC vacating judgments entered by the Eastern Dis...
Read Full ArticleCan You Enforce Trade Secrets in “Vibe-Coded” Systems?
AI-Assisted Development Is Reshaping Software Ownership, Confidentiality and Litigation Risk - Artificial intelligence (AI) is rapidly transforming how software is developed. More than ever, engineer...
Read Full ArticleU.S. Supreme Court Addresses Liability for Patent Infringement by Generic Pharmaceuticals
In a unanimous opinion by Justice Ketanji Brown Jackson, the U.S. Supreme Court held that Amarin, the developer of Vascepa® (reference listed drug), failed to plausibly allege that Hikma actively i...
Read Full ArticleAI Medical Technology Meets IP Law in Patent Infringement Suit
In April 2026, a complaint alleging “one of the most egregious examples of piracy in the medical technology industry” landed on the docket of the U.S. District Court for the Eastern District of Te...
Read Full ArticleHikma v. Amarin: It’s Not Just About Skinny Labels
Key Takeaways: In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889, the Supreme Court reversed the Federal Circuit and held that a generic drug manufacturer’s FDA-compliant skinn...
Read Full ArticleTrimming the Fat: Supreme Court Slims Down Skinny Label Liability
On June 4, 2026, the United States Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. In its decision, the Supreme Court reversed the Federal Circuit, and held ...
Read Full ArticleNavigating AI Liability Under the Revised NO FAKES Act
Generative artificial intelligence has made it easier than ever to replicate someone’s voice or face without their consent, and the law has struggled to keep pace....By: Fenwick & West LLP...
Read Full ArticleHikma v. Amarin: What the Supreme Court’s Decision Means for Skinny Labels and Induced Infringement
The Supreme Court has issued a unanimous decision in Hikma v. Amarin, holding that Amarin did not meet its pleading burden of plausibly alleging that Hikma induced infringement of Amarin’s patents r...
Read Full ArticleGeneric Manufacturers Given “Breathing Room” with Carve-Outs
Generic drug manufacturers have greater protection from claims of induced infringement in “skinny label” cases following a unanimous 9-0 victory before the U.S. Supreme Court in Hikma Pharmaceutic...
Read Full ArticleSupreme Court Rejects “Possibility” Standard for Induced-Infringement Claims Against Skinny-Label Generics
The Supreme Court issued a unanimous decision for Hikma in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. It reversed the Federal Circuit and held that Amarin failed to state a claim that Hikma...
Read Full ArticleMcDermott+ Check-Up – June 5, 2026
The Senate passed the reconciliation 2.0 package, which funds ICE and CBP and includes no healthcare provisions. The bill now moves to the House, though Republican leadership cancelled Friday votes, p...
Read Full ArticleSocial Links: The Online Safety Dance Continues
Youth-Safety Debate Moves Down-Stack - Utah is the latest state to push online youth-safety regulation beyond social media platforms themselves. A new law (H.B. 498) requires stores to verify users...
Read Full ArticleSix Petitions, Six Placeholders: The Patent Docket Awaiting the Supreme Court
A case-by-case look at the dozen patent petitions and applications pending at the Supreme Court, from settled expectations to prosecution laches. Continue reading this post on Patently-O....
Read Full ArticlePatents Don’t Monetize Themselves: Turning Portfolios from Cost Centers into Revenue Assets
Imagine a company spends millions of dollars constructing a new office building in a prime downtown location. The company pays for maintenance, utilities, insurance, landscaping, repairs, security, an...
Read Full ArticleAutomating the Patent Process at the USPTO to Save Inventors Money
Have you ever drafted a claim set with a second claim that began, “the system of claim 2, wherein…” when you meant to write “the system of claim 1”? It’s embarrassing because every first-y...
Read Full ArticleCAFC Rejects Inventor’s Sotera Stipulation Challenge against LG, Affirms Google and Microsoft Win at PTAB
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision Friday in Hafeman v. Google LLC affirming Patent Trial and Appeal Board (PTAB) final written decisions (FWDs) in...
Read Full ArticleIntegrity Versus Repose: When Claim Preclusion Bars Fraud on the Court
The Eleventh Circuit holds res judicata bars a patent-rooted fraud-on-the-court claim, even as Capital Security readies a Supreme Court petition. Continue reading this post on Patently-O....
Read Full ArticleReaders React: What to Expect After the Supreme Court’s Hikma Ruling
Thursday’s Supreme Court ruling in Hikma v. Amarin has been discussed as a definitive win for the generics industry and may have implications beyond pharmaceutical and Hatch-Waxman cases. The Court ...
Read Full ArticleOther Barks & Bites for Friday, June 5: Trump Auto Industry Comments Bolster REPAIR Act; House IP Subcommittee Debates Generics Legislation Following Hikma; and X Seeks Modificatio
This Week in Other Barks & Bites: the Seventh Circuit remands a Schedule A trademark case to determine whether the Hague Convention’s terms on proper service apply to particular Chinese defendants; ...
Read Full ArticleWhat the Verdict Might Have Said: Jury Black Boxes in Ollnova v. ecobee
In Ollnova v. ecobee, the Federal Circuit vacated a patent verdict over jury unanimity and a defective Alice step two charge on the abstract idea. Continue reading this post on Patently-O....
Read Full ArticleHarrity & Harrity is Seeking a Patent Prosecution Attorney/Agent for 5G/6G
Harrity & Harrity, LLP is looking for remote (within the U.S.) or local patent professional superstars to prosecute 5G patent applications for leading global technology companies, including numerous P...
Read Full ArticleConstellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
By Michael Borella – Eligibility wins at the Federal Circuit are scarce enough that any decision finding a claim to survive § 101 is worth a read. Constellation Designs, LLC v. LG Electronics Inc...
Read Full ArticleHikma Ruling Looms Large in House IP Subcommittee Hearing Debating Legislation Favoring Generic Drugmakers
At approximately the same moment that the U.S. Supreme Court handed down today’s landmark ruling in Hikma v. Amarin, the House Judiciary’s Subcommittee on Courts, Intellectual Property, Artificial...
Read Full ArticleForeseeable Is Not Inducing: Hikma v. Amarin
A unanimous Supreme Court holds that skinny-label inducement turns on what the generic actually did, not on how a physician might read it. Continue reading this post on Patently-O....
Read Full ArticleSCOTUS’ Hikma Ruling Changes the Game for Induced Infringement Pleadings
The U.S. Supreme Court today issued its decision in Hikma Pharmaceuticals USA v. Amarin Pharma, Inc., holding that Amarin failed to “plausibly allege” that Hikma actively induced infringement of i...
Read Full Article
Locations
USA Cambridge Office
245 First Street 18th Floor, Cambridge, MA 02142
China Shenzhen Office
Dun Huang Mansion, Suite 6C 49 Zi Zhu Liu Road, Zhu Zi Lin, Futian District Shenzhen 518040
Admissions: Admitted in MA, CAFC, and USPTO.
Privacy Policy
Effective Date: January 26, 2026
This Privacy Policy describes how Matthias Scholl (“we,” “us,” or “our”) collects, uses, and protects information obtained through this website (the “Site”).
By using this Site, you consent to the practices described in this Policy.
1. Information We Collect
We may collect the following categories of information:
a. Information You Voluntarily Provide
You may provide personal information to us when you:
- Contact us by email or through the Site
- Submit an inquiry
- Register for an event or mailing list
- Apply for a position
This information may include your name, email address, telephone number, company name, and any information you choose to provide in your message.
b. Automatically Collected Information
When you visit the Site, we may automatically collect:
- IP address
- Browser type and operating system
- Pages viewed and time spent on the Site
- Referring website
This information is collected through cookies and similar technologies for website functionality and analytics.
2. Cookies and Analytics
We use cookies and similar technologies to operate and improve the Site.
We use Google Analytics and Google Tag Manager to:
- Measure site usage
- Understand visitor behavior
- Improve website performance
These tools may collect information such as IP address, browser type, and usage patterns. Google may use this data in accordance with its own privacy policies.
You may disable cookies through your browser settings. Please note that disabling cookies may affect the functionality of the Site.
We do not use cookies for advertising, behavioral profiling, or sale of personal data.
3. How We Use Information
We use information collected through the Site to:
- Respond to inquiries and communications
- Provide legal and professional services
- Operate and improve the Site
- Maintain security and prevent misuse
- Comply with legal and ethical obligations
We do not sell personal information.
4. Disclosure of Information
We may disclose information:
- To service providers assisting in website hosting, analytics, or IT support
- When required by law, court order, or legal process
- To protect the rights, property, or safety of the firm or others
- In connection with a business transaction (e.g., merger or reorganization)
We do not disclose personal information for marketing purposes by third parties.
5. No Attorney–Client Relationship
Use of this Site or submission of information through it does not create an attorney–client relationship. Please do not submit confidential or time-sensitive information unless an attorney–client relationship has been formally established in writing.
6. Data Security
We use reasonable administrative and technical measures to protect personal information. However, no method of transmission over the internet is completely secure, and we cannot guarantee absolute security.
7. Data Retention
We retain personal information only as long as reasonably necessary for legitimate business and legal purposes, including compliance with legal and ethical obligations.
8. External Links
This Site may contain links to third-party websites. We are not responsible for the privacy practices or content of those sites. Please review their privacy policies separately.
9. Changes to This Policy
We may update this Privacy Policy from time to time. Any changes will be posted on this page with an updated effective date. Continued use of the Site constitutes acceptance of the revised policy.
10. Contact Information
If you have questions about this Privacy Policy, you may contact us through the contact information provided on this website.
Legal Disclaimer
The information on this website is provided by Matthias Scholl for general informational purposes only and does not constitute legal advice. Use of this website does not create an attorney–client relationship. An attorney–client relationship will be formed only through a written engagement agreement.
The materials on this website are not intended to address the circumstances of any particular matter, including patentability, infringement, freedom-to-operate, or other intellectual property issues. You should seek advice from a qualified attorney regarding your specific situation.
Links to third-party websites are provided for convenience only and do not constitute endorsement or approval of their content.
Contacting us by email or through this website does not create an attorney–client relationship. Please do not send confidential or sensitive information unless and until a formal engagement has been established. Electronic communications may not be secure.
If you do not receive a response from us, you should assume that we are unable to represent you and should seek legal counsel elsewhere. For assistance in locating a Massachusetts-admitted attorney, please visit: https://www.massbar.org/public/lawyer-referral-service.
This website may constitute attorney advertising under Massachusetts law. Prior results do not guarantee a similar outcome. Matthias Scholl practices law only in jurisdictions in which he is properly admitted or otherwise authorized to practice.